Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

SALT LAKE CITY, Feb. 01, 2024 -- Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, today announced it has completed the acquisition from Intermountain Health of select...

Related Keywords

Utah ,United States ,Glenn Farrell ,Matt Scalo ,Intermountain Health ,Nasdaq ,Exchange Commission ,Genetics Inc ,Globenewswire Inc ,Intermountain Precision Genomics ,Tumor Test ,Precise Liquid Test ,Precise Tumor Test ,Solid Tumor ,Precise Tumor ,Precise Liquid ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Markets ,